Status:
UNKNOWN
Is Thymus Size of Infants Who Born to COVID-19 Positive Mothers Associated With Neonatal Morbidities?
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
Covid19
Thymic Hypoplasia
Eligibility:
All Genders
Up to 7 years
Phase:
NA
Brief Summary
COVID-19 infected pregnant women is thought to have variable degrees of inflammatory response against the disease. Investigators of present study, suggested that fetuses are affected from the possible...
Detailed Description
COVID-19 infected pregnant women is thought to have variable degrees of inflammatory response against the disease. Fetus is known to be influenced by maternal systemic infections. Thymus size of fetus...
Eligibility Criteria
Inclusion
- Infants born to COVID-19 positive or negative mothers
- Accepted to participate with an informed consent
- Infants who required to get chest X-ray within the first 6 hours
Exclusion
- Infants whose mothers' have any kind of acute or chronic systemic disease or inflammation/infection
- Lack of an informed consent
- Infants who did not require to get chest X-ray within the first 6 hours
Key Trial Info
Start Date :
May 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04470739
Start Date
May 30 2020
End Date
October 30 2020
Last Update
July 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, Turkey (Türkiye), 34303